Creative Planning Acquires 11,554 Shares of Enovix Co. (NASDAQ:ENVX)

Creative Planning boosted its holdings in shares of Enovix Co. (NASDAQ:ENVXFree Report) by 53.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,084 shares of the company’s stock after purchasing an additional 11,554 shares during the period. Creative Planning’s holdings in Enovix were worth $511,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Blue Trust Inc. grew its holdings in shares of Enovix by 102.1% in the 2nd quarter. Blue Trust Inc. now owns 1,894 shares of the company’s stock worth $29,000 after purchasing an additional 957 shares during the last quarter. Beacon Capital Management LLC grew its stake in Enovix by 71.9% during the first quarter. Beacon Capital Management LLC now owns 4,298 shares of the company’s stock worth $34,000 after buying an additional 1,798 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Enovix by 11,176.2% during the second quarter. GAMMA Investing LLC now owns 2,368 shares of the company’s stock worth $37,000 after buying an additional 2,347 shares in the last quarter. Voisard Asset Management Group Inc. raised its stake in shares of Enovix by 25.0% in the second quarter. Voisard Asset Management Group Inc. now owns 5,000 shares of the company’s stock valued at $77,000 after acquiring an additional 1,000 shares during the last quarter. Finally, Game Plan Financial Advisors LLC boosted its holdings in shares of Enovix by 65.2% in the 1st quarter. Game Plan Financial Advisors LLC now owns 10,135 shares of the company’s stock worth $81,000 after acquiring an additional 4,000 shares in the last quarter. 50.92% of the stock is owned by institutional investors and hedge funds.

Enovix Stock Up 0.2 %

NASDAQ ENVX opened at $12.81 on Tuesday. The company has a market cap of $2.18 billion, a price-to-earnings ratio of -9.56 and a beta of 1.98. Enovix Co. has a 1-year low of $5.70 and a 1-year high of $18.68. The company has a current ratio of 3.98, a quick ratio of 3.84 and a debt-to-equity ratio of 0.97. The company has a 50 day moving average of $9.94 and a 200-day moving average of $10.79.

Enovix (NASDAQ:ENVXGet Free Report) last released its earnings results on Wednesday, July 31st. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Enovix had a negative return on equity of 91.21% and a negative net margin of 1,434.34%. The firm had revenue of $3.77 million during the quarter, compared to the consensus estimate of $3.85 million. On average, equities research analysts expect that Enovix Co. will post -1.21 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ENVX has been the topic of a number of research analyst reports. Piper Sandler reissued an “overweight” rating and set a $19.00 price objective (down previously from $23.00) on shares of Enovix in a report on Monday, August 5th. Canaccord Genuity Group raised their price target on shares of Enovix from $17.00 to $20.00 and gave the company a “buy” rating in a report on Thursday, August 1st. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $30.00 price objective on shares of Enovix in a report on Thursday, August 1st. Craig Hallum lifted their target price on Enovix from $15.00 to $20.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $36.00 price target on shares of Enovix in a research note on Monday, August 26th. One research analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Enovix presently has a consensus rating of “Buy” and a consensus target price of $21.33.

View Our Latest Research Report on ENVX

Enovix Company Profile

(Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

See Also

Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Co. (NASDAQ:ENVXFree Report).

Institutional Ownership by Quarter for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.